Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...

As artificial intelligence systems become smarter, one A.I. company is trying to figure out what to do if they become ...

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

Bhavya Kadiyala is a Business Intelligence Specialist at Parkland Health and Hospital System in Dallas, Texas. With over nine ...

Hans Warrinnier, chief medical officer at Bioxodes, said in a statement that the results are preliminary but all point in the ...

Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely ...

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people with overweight or ...

As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...

Wilson Community College is building a biotechnology and workforce center to prepare students for jobs in the biotech ...

The report warns, "Our window to act is closing. We need a two-track strategy: make America innovate faster, and slow China ...

China’s Supreme People’s Court (SPC) the Typical Intellectual Property Cases in People’s Courts of 2024 (2024年人民法院知识产权典型案例).